Health body previously gave similar recommendation on Pfizer-BioNTech shot, a position rejected by Israel amid a spike in serious cases

Countries choose between American Pfizer and Chinese Sinopharm shots, as Beijing pursues its 'Belt and Road' globe-spanning infrastructure and trade network push

Trial now to be increased to 300 volunteers; Tehran hopes to have 3 local COVID-19 vaccines available to public by June, having banned Western vaccines

Figure represents 0.015 percent of people, indicating vaccine is hitting 95% efficiency rate predicted by clinical trials; top immunologist hails 'exciting results'

Pfizer says efficacy of shot after such a long period is untested; Israeli virus czar had claimed 1st dose less effective than anticipated

US pharmaceutical company commits to World Health Organization's COVAX program as wealthy countries snap up most vaccine supplies

After Nachman Ash quoted as saying first shot of vaccine provides less protection than company initially indicated, Health Ministry says comments taken out of context

As trend starts reversing, deputy health minister says that while infections are now waning, the decline is blunted by the fast-spreading British mutation of the virus

Epidemiological interest clear, say officials, warning that herd immunity cannot be reached otherwise, but legal experts conflicted over whether Israel is ultimately responsible

Research comes as spread of more transmissible UK strain raises global concerns, with top Israeli health official saying it now accounts for 30%-40% of new cases in country